SITM enters its August 5 earnings date with a striking divergence between a broadly bullish analyst consensus and the most defensive options positioning the stock has seen in nearly a year.
The options signal is the sharpest data point on the board right now. The put/call ratio jumped to 1.01 on July 20 — more than two standard deviations above its 20-day average of 0.63, a z-score of 2.12. That reading is the highest the ratio has been in the past year, short of the brief spike to 1.10 seen at the end of June. The move is stark given the prior three weeks sat consistently below 0.70, suggesting Friday's session saw a meaningful one-day rotation into downside protection. The stock itself has fallen 24% over the past month to $555.15, and dropped another 8% on the week, slightly worse than closest peer MTSI, which lost 8.3% over the same stretch. MRAM fared worse at -15%, while MKSI fell 7.9%, placing SITM broadly in line with a sector-wide bid retreat.
Short interest, by contrast, tells a less alarming story than the options move implies. Bears have actually been covering — the estimated short position dropped 14% over the past month to roughly 3.6% of the free float, a level that sits in the mid-range and carries no meaningful squeeze risk. The borrow market is completely relaxed: availability runs at nearly 2,906% of shares already short, meaning shares to borrow are abundant by any measure. Cost to borrow has eased to 0.34% after touching 0.60% at end-June, a level that is near the lowest it has been all month. Nothing in the lending market suggests bear conviction is building — short sellers were reducing exposure even as the stock was selling off hard in June and early July.
The Street remains constructively positioned, but the catalyst that drove most of the enthusiasm is now 10 weeks old. Following the May earnings print — when the stock surged 34% in a single day — UBS raised its target to $775, Barclays upgraded to Overweight with an $850 target, and Needham moved its target to $850 from $450. All five analysts tracked carry Buy or equivalent ratings, with a consensus mean target of $837.50 against the current price of $555. That gap of roughly 51% sounds generous, but the analyst data is dated to mid-June and targets were set on a stock trading near $750. The valuation has compressed sharply: the PE multiple has fallen 26 points over the past month to 52x, and EV/EBITDA has contracted by more than 20 turns to 35.8x. On EPS momentum the stock ranks in the 89th and 97th percentiles on 30- and 90-day windows respectively — the forward growth story is not in question. What is being repriced is the multiple investors are willing to pay for it.
The insider picture adds one more cautious data point. In mid-June, CEO Rajesh Vashist sold 20,000 shares at prices between $700 and $750 — generating roughly $15 million — while the CLO and two Executive Vice Presidents also sold. All trades occurred when the stock was trading 25-35% above today's levels. The net 90-day insider position, however, is net positive at roughly 522,000 shares because of earlier activity; the June cluster of sales reads more as opportunistic trimming at the top than a directional call on the business.
August 5 is therefore the fulcrum: with the stock down nearly a quarter from the post-earnings high, the question is whether SITM's next print can reignite growth enthusiasm at a lower multiple base, or whether the defensive options positioning heading into the release reflects something the market knows that the still-bullish analyst consensus does not yet.
See the live data behind this article on ORTEX.
Open SITM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
